“…Efforts to develop a successful vaccine against NTHi are ongoing, with several antigenic virulence factors that contribute to the early stages of bacterial colonization under consideration as potential vaccine candidates (11)(12)(13). Several proteins are under investigation as vaccine candidates (11,14), including fimbriae (OMP P5-homologous fimbriae (15)), outer membrane proteins (OMPs) (P2, P6) (16,17), transferrin binding proteins (TbpB) (18), protein D (19), PilA (major subunit of type IV pili) (20), Hia (21), Hap (22), and HMW1/2 (14,23). However, vaccine development is impeded by the high variability and heterogeneity of NTHi, especially of their surface molecules (13,24).…”